What Does a Positive Bubble Study on Echocardiogram Imply?
A positive bubble study on echocardiogram primarily indicates the presence of an intracardiac shunt, most commonly a patent foramen ovale (PFO), which allows abnormal blood flow between the right and left sides of the heart. 1
Understanding Bubble Studies
A bubble study (also called contrast echocardiography) involves injecting agitated saline solution into a peripheral vein during an echocardiogram. The agitated saline creates microbubbles that are visible on ultrasound. In normal circulation:
- Microbubbles appear in the right side of the heart
- Bubbles are filtered by the lungs
- No bubbles should appear in the left side of the heart
Interpretation of Results
When bubbles appear in the left side of the heart:
- Early appearance (within 3-8 cardiac cycles): Indicates an intracardiac shunt, typically a PFO 1
- Delayed appearance (>8 cardiac cycles): Suggests an intrapulmonary shunt such as pulmonary arteriovenous malformation (PAVM) 1
Clinical Significance of a Positive Bubble Study
1. Patent Foramen Ovale (PFO)
The most common finding in a positive bubble study is a PFO, which is present in approximately 20% of the general population 2. A PFO represents a persistent opening between the right and left atria that failed to close after birth.
Clinical implications of PFO:
- Increased stroke risk: PFO presence in patients with pulmonary embolism increases the risk of death (relative risk 2.4) and ischemic stroke (relative risk 5.9) 1
- Paradoxical embolism: Allows emboli to bypass the pulmonary circulation and enter the systemic circulation 1
- Hypoxemia: Can contribute to hypoxemia in certain clinical scenarios 1
2. Other Intracardiac Shunts
A positive bubble study may also indicate:
- Atrial septal defect
- Ventricular septal defect
- Other congenital heart abnormalities 1
3. Pulmonary Arteriovenous Malformations
When bubbles appear in the left heart after a delay of more than 3-8 cardiac cycles, this suggests a PAVM rather than an intracardiac shunt 1.
Clinical Applications and Risk Stratification
A positive bubble study has several important clinical applications:
Cryptogenic stroke evaluation: Essential in young patients with stroke of unknown origin 3
Risk stratification in pulmonary embolism: The presence of a PFO in patients with PE is an independent predictor of adverse events 1
Screening high-risk populations: Including:
- Individuals with known genetic mutations associated with pulmonary arterial hypertension
- First-degree relatives with idiopathic pulmonary arterial hypertension
- Patients with scleroderma spectrum disease
- Patients with congenital heart disease
- Patients with portal hypertension before liver transplantation 1
Quantification of shunt severity: The number of bubbles appearing in the left heart can be graded:
- Grade 1: <30 bubbles
- Grade 2: Moderate filling
- Grade 3: Complete opacification of the left atrium 1
Clinical Management Implications
The detection of a PFO or other shunt through a positive bubble study may influence management decisions:
- In cryptogenic stroke: May lead to consideration of PFO closure 4
- In pulmonary embolism: Patients with intracardiac shunts should be considered for aggressive therapeutic options, including catheter-based techniques or surgical embolectomy 1
- In pulmonary hypertension: Helps in comprehensive evaluation and risk stratification 1
Limitations and Considerations
- False positives and false negatives can occur 5
- TEE bubble studies have higher sensitivity (89.2%) and specificity (91.4%) compared to transthoracic echocardiography 2
- Complications are rare but possible (reported TIA risk of 0.1%) 4
Key Points for Clinicians
- A positive bubble study should prompt consideration of the clinical context
- Not all PFOs require intervention - management depends on clinical presentation and associated conditions
- In patients with cryptogenic stroke, a positive bubble study may guide secondary prevention strategies
- The combination of bubble test with other non-invasive tests (like carotid ultrasound) can help determine the need for more invasive testing such as transesophageal echocardiography 3